Genzyme Sues Roxane Again Over Generic Hectorol

Law360, New York (July 27, 2010, 2:28 PM EDT) -- Biotechnology company Genzyme Corp. has launched another patent infringement suit over Roxane Laboratories Inc.’s plans to market a generic version of chronic kidney disease treatment Hectorol.

Cambridge, Mass.-based Genzyme filed the latest suit in the U.S. District Court for the District of Delaware on Friday, seeking to block Roxane from making and selling generic capsules containing doxercalciferol before the expiration of U.S. Patent Number 5,602,116.

The suit follows an earlier case brought by Genzyme in Delaware in July 2009 after Roxane asked the U.S. Food and...
To view the full article, register now.